Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	FOLFOX4	1,151
Overall Study	STARTED	FOLFOX4 + Bv	1,155
Overall Study	STARTED	XELOX+Bv	1,145
Overall Study	Received Treatment	FOLFOX4	1,126
Overall Study	Received Treatment	FOLFOX4 + Bv	1,145
Overall Study	Received Treatment	XELOX+Bv	1,135
Overall Study	Stage III Disease Population	FOLFOX4	955
Overall Study	Stage III Disease Population	FOLFOX4 + Bv	960
Overall Study	Stage III Disease Population	XELOX+Bv	952
Overall Study	COMPLETED	FOLFOX4	854
Overall Study	COMPLETED	FOLFOX4 + Bv	810
Overall Study	COMPLETED	XELOX+Bv	846
Overall Study	NOT COMPLETED	FOLFOX4	297
Overall Study	NOT COMPLETED	FOLFOX4 + Bv	345
Overall Study	NOT COMPLETED	XELOX+Bv	299

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00112918/flow